Heartbeam Competitors

Stocks . USA . 
Stock . Heartbeam
BEAT Stock  USD 2.80  0.03  1.06%   
Heartbeam competes with FOXO Technologies, EUDA Health, Nutex Health, Healthcare Triangle, and Bullfrog; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Heartbeam competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Heartbeam to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Heartbeam Correlation with its peers.
For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Heartbeam competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.142.807.45
Details
Intrinsic
Valuation
LowRealHigh
0.112.196.84
Details
Naive
Forecast
LowNextHigh
0.063.017.65
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.152.512.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Heartbeam. Your research has to be compared to or analyzed against Heartbeam's peers to derive any actionable benefits. When done correctly, Heartbeam's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Heartbeam.

Heartbeam Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Heartbeam and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Heartbeam and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Heartbeam does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NUTX
+ 0.69
FOXO
LIFW
+ 0.67
MGRX
HCTI
+ 0.57
NUTX
HCTI
+ 0.54
FOXO
LIFW
+ 0.49
BFRG
HCTI
+ 0.47
EUDA
  
High negative correlations   
LIFW
- 0.68
NUTX
MGRX
- 0.62
HCTI
LIFW
- 0.61
FOXO
MGRX
- 0.6
EUDA
LIFW
- 0.59
HCTI
BFRG
- 0.55
NUTX

Risk-Adjusted Indicators

There is a big difference between Heartbeam Stock performing well and Heartbeam Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Heartbeam's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Heartbeam Competitive Analysis

The better you understand Heartbeam competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Heartbeam's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Heartbeam's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BEAT FOXO EUDA UTRS NUTX HCTI BFRG MGRX LIFW
 1.06 
 2.80 
Heartbeam
 35.90 
 0.53 
FOXO
 1.62 
 4.39 
EUDA
 0.00 
 0.26 
Minerva
 1.58 
 34.76 
Nutex
 6.74 
 0.83 
Healthcare
 4.05 
 2.13 
Bullfrog
 5.34 
 2.48 
Mangoceuticals,
 9.88 
 1.55 
MSP
Market Volatility
(90 Days Market Risk)
Very risky
Out of control
Very risky
Very steady
Not too volatile
Out of control
Dangerous
Dangerous
Extremely Dangerous
Market Performance
(90 Days Performance)
OK
OK
Weak
Very Weak
OK
Modest
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
About Average
Very High
Dangerous
Above Average
Average
Low
Very High
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Sell
Not Rated
Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
12.65
0.31
N/A
2.4
4.43
1.42
N/A
N/A
N/A
Net Asset
17.13 M
725 K
1.31 M
68.9 M
398.25 M
10.05 M
2.78 M
1.05 M
3.16 B
Profit Margin
N/A
N/A
N/A
-0.65
-0.14
-0.49
N/A
N/A
N/A
EBITDA
675 K
(24.25 M)
(8.3 M)
(30.88 M)
(14.58 M)
(4.1 M)
(5.28 M)
(9.19 M)
(69.22 M)
Current Valuation
69.7 M
44.84 M
162.97 M
42.81 M
442.38 M
6.1 M
15.28 M
6.71 M
760.77 M
Price To Book
15.72
0.91
N/A
0.51
3.08
0.87
5.06
0.49
0.0109
Operating Margin
N/A
-56.75
-0.83
-0.51
0.13
-0.46
-96.73
-13.05
-400.37
Retained Earnings
(36.83 M)
(177.06 M)
(34.74 M)
(283.67 M)
(409.07 M)
(24.91 M)
(9.75 M)
(11.23 M)
(85.55 M)
Current Asset
47.05 M
N/A
N/A
N/A
N/A
30 K
N/A
N/A
N/A
Beta
-0.99
2.06
-0.004
0.83
1.79
0.49
N/A
N/A
-2.29
Number Of Employees
15
N/A
106
174
800
22
8
3
88
Shares Outstanding
26.67 M
17.48 M
37.15 M
8.88 M
5.44 M
5.67 M
8.71 M
2.49 M
1.24 M
Cash Flow From Operations
(12.09 M)
(6.64 M)
(2.92 M)
(35.57 M)
1.26 M
(1.61 M)
(6 M)
(7 M)
(40.02 M)
Total Debt
1.19 M
4.2 M
3.37 M
39.69 M
275.76 M
4.32 M
184.35 K
128.68 K
679.33 M
Return On Equity
-1.14
-17.55
N/A
-1.6
-0.35
-2.88
-1.18
-1.08
-0.59
Z Score
N/A
N/A
N/A
-5.93
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.7
-1.14
-0.86
-0.27
0.0376
-0.55
-0.65
-0.58
-0.11
Number Of Shares Shorted
155.92 K
53.71 K
5.04 K
37.42 K
35.67 K
632.84 K
255.31 K
194.4 K
1.16 M
Book Value Per Share
0.61
-1.84
-0.17
2.28
11.59
0.13
0.43
0.54
18.58
Current Liabilities
23.89 M
N/A
N/A
N/A
N/A
10.13 M
N/A
N/A
N/A
Total Asset
17.13 M
725 K
1.31 M
68.9 M
398.25 M
10.05 M
2.78 M
1.05 M
3.16 B
Debt To Equity
0.52
N/A
N/A
1.3
0.44
0.23
N/A
N/A
N/A
Short Ratio
1.64
0.24
0.09
0.51
0.74
0.09
2.3
0.21
0.37
Target Price
5.0
N/A
6.0
3.0
55.33
1.5
N/A
N/A
3.0
Shares Owned By Institutions
8.73
2.25
2.47
89.86
8.8
3.27
3.48
4.69
20.17
Market Capitalization
75.46 M
9.2 M
160.59 M
13.14 M
186.05 M
5.04 M
19.34 M
6.51 M
9.98 M
Price To Earning
149.92
N/A
N/A
N/A
3.9
N/A
N/A
N/A
N/A
Price To Earnings To Growth
1.67
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
N/A
59.36
42.13
0.25
0.64
0.23
297.59
7.52
1.57
Net Income
(14.64 M)
(26.45 M)
(8.43 M)
(34.11 M)
(45.79 M)
(12.34 M)
(5.36 M)
(9.21 M)
(56.35 M)
Earnings Per Share
-0.68
0.05
-0.62
-7.61
-9.18
-2.17
-0.84
-5.7
-141.5
Shares Owned By Insiders
29.24
11.99
49.35
0.43
39.05
45.93
29.2
37.45
14.9
Revenue
N/A
145 K
3.71 M
50.29 M
247.65 M
33.2 M
65 K
731.49 K
7.71 M
Working Capital
15.63 M
(14.1 M)
(7.99 M)
21.84 M
32.54 M
(2.39 M)
2.59 M
607.38 K
(24.56 M)
Cash And Equivalents
9.27 M
18.5 M
N/A
22.39 M
47.6 M
1.36 M
N/A
N/A
N/A
Cash Per Share
1.16
5.22
N/A
0.78
0.07
0.04
N/A
N/A
N/A
Gross Profit
N/A
120 K
3.35 M
27.24 M
36.3 M
10.52 M
N/A
4.85 K
14.44 M
Day Typical Price
2.85
0.57
4.46
0.26
34.58
0.86
2.18
2.52
1.62
Accumulation Distribution
0.0867
0.44
0.0812
0.037
0.055
0.0978
0.11
0.072
0.13
Market Facilitation Index
0.26
0.33
0.38
0.01
1.95
0.09
0.25
0.19
0.23
Daily Balance Of Power
(0.12)
0.4242
0.1842
N/A
0.2769
(0.67)
(0.36)
(0.74)
(0.74)
Period Momentum Indicator
(0.03)
0.14
0.07
N/A
0.54
(0.06)
(0.09)
(0.14)
(0.17)
Rate Of Daily Change
0.99
1.36
1.02
1.0
1.02
0.93
0.96
0.95
0.9
Day Median Price
2.87
0.59
4.49
0.27
34.49
0.88
2.21
2.55
1.66
Price Action Indicator
(0.09)
0.015
(0.07)
(0.01)
0.54
(0.07)
(0.12)
(0.14)
(0.19)
Relative Strength Index
59.81
54.64
50.79
49.69
60.95
45.44
44.97
42.48
32.85
Coefficient Of Variation
980.4
829.88
6498.93
N/A
749.29
1320.23
(11,139)
(2,582)
(449.38)
Mean Deviation
3.31
17.43
4.6
N/A
5.29
7.95
3.59
4.26
5.75
Jensen Alpha
0.5916
1.97
0.1332
N/A
0.8776
1.83
(0.12)
(0.25)
(1.92)
Total Risk Alpha
(0.27)
(2.15)
(0.89)
N/A
(0.19)
(1.50)
(0.98)
(1.18)
(3.00)
Sortino Ratio
0.0931
0.4687
(0)
N/A
0.1473
0.121
N/A
N/A
N/A
Downside Variance
13.6
212.32
52.25
N/A
32.76
106.51
N/A
N/A
N/A
Standard Deviation
4.65
57.76
6.21
N/A
7.29
18.21
5.83
5.96
7.88
Kurtosis
1.36
59.14
1.23
N/A
5.92
33.67
14.53
5.33
3.38
Potential Upside
10.3
35.14
9.7
N/A
11.24
9.92
6.72
7.29
9.88
Treynor Ratio
(0.44)
0.1679
(0.22)
N/A
1.35
(0.36)
(0.12)
(2.31)
(1.34)
Maximum Drawdown
22.69
509.71
25.66
N/A
47.75
142.49
41.78
37.65
40.15
Variance
21.59
3336.34
38.52
N/A
53.18
331.69
34.02
35.48
62.08
Market Risk Adjusted Performance
(0.43)
0.1779
(0.21)
N/A
1.36
(0.35)
(0.11)
(2.30)
(1.33)
Risk Adjusted Performance
0.0863
0.102
0.0205
N/A
0.111
0.0675
0.0018
(0.02)
(0.16)
Skewness
0.8346
7.49
(0.61)
N/A
1.46
4.96
2.82
1.5
0.9391
Semi Deviation
3.18
9.49
6.84
N/A
5.19
8.94
N/A
N/A
N/A
Information Ratio
0.0739
0.1182
(0.01)
N/A
0.1156
0.0686
(0.03)
(0.06)
(0.24)
Value At Risk
(6.23)
(10.00)
(10.50)
N/A
(8.45)
(18.35)
(6.97)
(7.65)
(14.04)
Expected Short fall
(4.12)
(36.66)
(4.43)
N/A
(6.20)
(11.55)
N/A
N/A
N/A
Downside Deviation
3.69
14.57
7.23
N/A
5.72
10.32
N/A
N/A
N/A
Semi Variance
10.08
90.09
46.75
N/A
26.94
79.87
N/A
N/A
N/A

Heartbeam Competition Performance Charts

Five steps to successful analysis of Heartbeam Competition

Heartbeam's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Heartbeam in relation to its competition. Heartbeam's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Heartbeam in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Heartbeam's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Heartbeam, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Heartbeam position

In addition to having Heartbeam in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Information Technology ETFs Thematic Idea Now

Information Technology ETFs
Information Technology ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Heartbeam Stock Analysis

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY